Both in Pharmaceuticals
Immix Biopharma vs Zevra Therapeutics
Over the past year IMMX returned +114.0% and ZVRA returned +6.6%; their daily moves had a correlation of 0.27.
IMMX +114.0% ZVRA +6.6%Growth of $1, one year, split-adjusted
| Metric | IMMX | ZVRA |
|---|---|---|
| Price | $7.79 | $10.88 |
| Market cap | $645.8M | $646.1M |
| Today | +1.04% | +6.04% |
| 1 month | −19.2% | +1.4% |
| 6 months | −24.5% | −3.3% |
| Year to date | +48.9% | +21.4% |
| 1 year | +114.0% | +6.6% |
| Revenue growth (YoY) | — | +44.9% |
| Gross margin | — | 95.2% |
| Net margin | — | 48.8% |
| P/E (TTM) | — | 8.4× |
| Price / sales | — | 4.4× |
| Net cash | $232.1M | $188.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.0% | 45.9% |
| Short % of float | 22.5% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).